PAM
CABA icon

Panagora Asset Management’s Cabaletta Bio CABA Stock Holding History

Panagora Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-173,518
Closed -$394K – 1118
2024
Q4 		$394K Sell
173,518
-145,853
-46% -$512K ﹤0.01% 887
2024
Q3 		$1.51M Buy
319,371
+19,570
+7% +$113K 0.01% 599
2024
Q2 		$2.24M Buy
+299,801
New +$3.67M 0.01% 488

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's CABA Position: Q1 2025 in Review

Panagora Asset Management sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 173,518 shares — an estimated $394K sold.

Panagora Asset Management first reported a position in CABA in Q2 2024 and held it in 3 quarters. The position peaked at $2.24M in Q2 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Panagora Asset Management reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Panagora Asset Management sold 173,518 Cabaletta Bio shares in Q1 2025, an estimated $394K.
  • Panagora Asset Management first reported a position in Cabaletta Bio in Q2 2024 and held it in 3 quarters.
  • Panagora Asset Management's Cabaletta Bio position peaked at $2.24M in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Panagora Asset Management's 13F filing for Q1 2025, filed 15 May 2025.